NLS Pharmaceutics Announces Preclinical Results Confirming the Potential Benefit and Safety Profile of NLS-4 for Circadian Rhythm Dysregulation and Chronic Fatigue Syndrome in Long-Covid Model

3 years ago

STANS, SWITZERLAND / ACCESSWIRE / November 30, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss…

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

3 years ago

FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…

NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line

3 years ago

VANCOUVER, BC / ACCESSWIRE / November 30, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology…

Data on naptumomab estafenatox enhancing CAR-T cells potency presented by Active Biotech’s partner NeoTX at SITC 2021

3 years ago

Lund, Sweden — November 30, 2021 – Active Biotech and its partner NeoTX announced that the preclinical data on naptumomab enhancing the…

OnePoint Patient Care Expands Its Local Hospice Pharmacy Model Throughout Texas

3 years ago

TEMPE, Ariz., Nov. 30, 2021 (GLOBE NEWSWIRE) --  OnePoint Patient Care (OnePoint) is continuing to expand its high-touch local hospice…

PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region

3 years ago

Strategic hire will expand Company’s commercial presence in key geographyMENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB),…

Dr. Henry Ji to Participate in the CEO Fireside Chat Evercore ISI 4th Annual HealthCONx Conference

3 years ago

SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji,…

Emergex confirms its next generation T-Cell Priming COVID-19 vaccine candidate has the potential to be effective against all currently sequenced viral mutations

3 years ago

PRESS RELEASE Emergex confirms its next generation T-Cell Priming COVID-19 vaccine candidate has the potential to be effective against all…

Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study

3 years ago

NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the…

RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81

3 years ago

Glen Rock, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader…